TYG-100
N/A
Report date: 2023/06/27 15:01:29
Base Information
Drug NameTYG-100
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOncoQR ML GmbHTYG Oncology Ltd
China Registration ClassN/A
Develop Information
Active CompaniesYurui Pharmaceutical Technology (Shanghai) Co LtdApollomics IncTYG Oncology Ltd +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A